Clinical Trial Update: Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on using levetiracetam to treat panic disorder and lactate-induced panic attacks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• Levetiracetam (Keppra) (levetiracetam)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Panic Disorder | Phase 3 | Status: COMPLETED